S. D. Molli et al. / Bioorg. Med. Chem. 20 (2012) 681–686
685
H-19); MS (ESI): m/z 721.2/723.2/725.2 (1:2:1) ([M-OH]+), 761.2/
m
max = 3386 (br), 1705, 1037, 699, 666 cmꢁ1
;
1H NMR (600 MHz,
763.2/765.2 (1:2:1) ([M+Na]+); HRMS (ESI): calcd for C34H4879Br2
N2O6Na ([M+Na]+) 761.1771, found 761.1794.
CD3OD): d = 3.52 (2H, t, J = 6.6 Hz, H-1), 3.41 (1H, dd, J = 10.6,
6.3 Hz, H-16b), 3.32 (1H, dd, J = 10.6, 6.6 Hz, H-16a), 2.54 (2H, t, J
8 6.6 Hz, H-5), 2.42–2.52 (2H, m, H-3), 1.75 (2H, quint, J = 6.6 Hz,
H-2), 1.60 (1H, m, H-6b), 1.58 (1H, m, H-15), 1.28–1.46 (12H, m),
1.13 (1H, m, H-8a), 1.12 (3H, s, H-18), 1.08 (1H, m, H-14a), 0.91
(3H, d, J = 7.0 Hz, H-17), 0.88 (3H, d, J = 6.6 Hz, H-19); 13C NMR
(150 MHz, CD3OD): d = 17.1 (C-17), 19. (C-19), 22.3 (C-9 or 13),
22.4 (C-13 or 9), 26.9 (C-18), 27.7 (C-2), 31.9 (C-6), 33.6 (C-7),
35.1 (C-14), 36.9 (C-15), 38.6 (C-8), 39.8 (C-3), 41.3 (C-5), 43.0
(C-10 and 12), 62.2 (C-1), 68.5 (C-16), 73.4 (C-11), 213.9 (C-4);
HRMS (ESI): calcd for C19H38O4Na ([M+Na]+) 353.2662, found
353.2638.
4.3.4. Dihydro-a1 (8)
To a solution of 1 (0.1 mg) in MeOH (0.1 mL) was added NaBH4
(1 mg), and the mixture was stirred at room temperature for 14 h.
The mixture was diluted with water and extracted with EtOAc. The
combined extracts were washed with water and concentrated. The
residue was chromatographed on silica gel with CHCl3-MeOH
(95:5, 9:1) to give 8 (0.05 mg): 1H NMR (CD3OD, 600 MHz):
d = 3.64 (1H, m, H-1b), 3.56 (1H, m, H-1a), 3.41 (1H, dd, J = 10.8,
.5.4 Hz, H-16b), 3.33 (1H, dd, J = 10.8, 4.2 Hz, H-16a), 3.34/3.42 (to-
tal 1H, m, H-4), 1.69/1.73 (1H, m, H-2b), 1.65 (1H, m, H-3), 1.58
(1H, m, H-15), 1.27–1.55 (15H, m), 1.05–1.17 (2H, m, H-8a, 14a),
1.12 (3H, s, H-18), 0.91 (3H, d, J = 6.6 Hz, H-17), 0.90 (3H, m, H-
19), 0.88/0.91 (total 3H, m, H-20); HRMS (ESI): calcd for
4.3.8. 1-O-Acetyl-
diacetyl- 2 (14)
Hormone 2 (2) (0.55 mg) was treated with acetic anhydride in
a2 (12), 16-O-acetyl-a2 (13), and 1,16-O,O-
a
a
C
20H43O4 ([M+H]+) 347.3156, found 347.3141; calcd for
C20H42O4Na ([M+Na]+) 369.2975, found 369.2968.
pyridine at room temperature for 30 min. TLC analysis [hexane-
EtOAc (1:1)] showed that the most of 2 was converted to diacetate
14 with small amounts of monoacetates. Another 2 (0.55 mg) was
acetylated under the same conditions except for the reaction time
of 5 min, producing additional monoacetates. The crude products
from the two reactions were combined and subjected to prepara-
tive TLC [20 cm ꢀ 10 cm ꢀ 0.25 mm thickness, hexane-EtOAc
(1:1)] to give 12 (0.3 mg, Rf = 0.3), 13 (0.2 mg, Rf = 0.42), and 14
(0.6 mg, Rf = 0.81). 12: 1H NMR (600 MHz, CDCl3): d = 5.33 (1H, t,
J = 7.0 Hz, H-2), 4.59 (2H, d, J = 7.0 Hz, H-1), 3.51 (1H, dd, J = 10.2,
6.0 Hz, H-16b), 3.44 (1H, dd, J = 10.2, 6.6 Hz, H-16a), 2.05 (3H, s,
Ac), 2.00 (2H, m, H-4), 1.69 (3H, s, H-20), 1.65 (1H, m, H-15),
1.20–1.50 (16H, m), 1.07–1.20 (3H, m, H-6a, 8a, and 14a), 1.16
(3H, s, H-18), 0.93 (3H, d, J = 6.6 Hz, H-17), 0.87 (3H, d, J = 6.6 Hz,
H-19)8; HRMS (ESI): calcd for C22H42O4Na ([M+Na]+) 393.2975,
found 393.2997.
4.3.5. Dehydrated
To a solution of diacetyl-
was added thionyl chloride (10
a1 (9)
a
1 (3) (0.6 mg) in dry pyridine (0.3 mL)
L) at 0 °C, and the mixture was
l
stirred for 30 min at 0 °C. The reaction mixture was diluted with
saturated NaHCO3 and extracted with hexane-EtOAc (1:1). The
combined extracts were washed with 1 M HCl and then water.
The organic layer was concentrated to give crude product
(0.4 mg). To a solution of the crude product in MeOH (0.5 mg)
was added K2CO3 (5 mg), and the mixture was stirred at room tem-
perature for 2 h. The reaction was quenched by adding saturated
NH4Cl (1 mL), and the mixture was extracted with EtOAc. The com-
bined extracts were washed with water and concentrated. The
resulting product was purified by HPLC [Develosil ODS-UG-5
(4.6 ꢀ 250 mm), 30–70% (40 min) MeCN, 4 mL/min, detected at
13: 1H NMR (600 MHz, CDCl3): d = 5.41 (1H, t, J = 6.6 Hz, H-2),
4.15 (2H, d, J = 6.6 Hz, H-1), 3.96 (1H, dd, J = 10.5, 5.7 Hz, H-16b),
3.86 (1H, dd, J = 10.5, 7.0 Hz, H-16a), 2.05 (3H, s, Ac), 1.99 (2H,
m, H-4), 1.80 (1H, m, H-15), 1.67 (3H, s, H-20), 1.20–1.50 (16H,
m), 1.16 (3H, s, H-18), 1.05–1.20 (3H, m, H-6a, 8a, and 14a), 0.94
(3H, d, J = 6.6 Hz, H-17), 0.87 (3H, d, J = 6.6 Hz, H-19); HRMS
(ESI): calcd for C22H42O4Na ([M+Na]+) 393.2975, found 393.2995.
14: 1H NMR (600 MHz, CDCl3): d = 5.33 (1H, t, J = 7.0 Hz, H-2),
4.59 (2H, d, J = 7.0 Hz, H-1), 3.96 (1H, dd, J = 10.8, 6.0 Hz, H-16b),
3.86 (1H, dd, J = 10.8, 7.0 Hz, H-16a), 2.05 (6H, s, Ac), 2.01 (2H,
m, H-4), 1.80 (1H, m, H-15), 1.69 (3H, s, H-20), 1.20–1.50 (15H,
m), 1.16 (1H, m, H-14a), 1.16 (3H, s, H-18), 1.10 (2H, m, H-6a
and 8a), 0.94 (3H, d, J = 6.6 Hz, H-17), 0.87 (3H, d, J = 6.0 Hz, H-
19); HRMS (ESI): calcd for C24H44O5Na ([M+Na]+) 435.3081, found
435.3079.
205 nm] to give
9
(tR = 37.1 min, 0.2 mg): 1H NMR (CDCl3,
600 MHz): d = 5.10 (0.66H, t, J = 6.3 Hz, H-10, 12), 4.70 (0.68H, s,
H-18), 3.65 (2H, m, H-1), 3.51 (1H, m, H-16b), 3.44 (1H, m,
H-16a), 2.75 (1H, sex, J = 6.8 Hz, H-3), 2.49 (2H, m, H-5), 1.94
(1H, m, H-2b), 1.92–2.08 (4H, m, H-9b, 10, 12, 13b), 1.63 (1H, m,
H-15), 1.59 (1H, m, H-2a), 1.58 (2H, s, H-18), 1.25–1.65 (9.7H,
m), 1.15 (1H, m, H-8), 1.13 (1H, m, H-14), 1.12 (3H, d, J = 7.0 Hz,
H-20), 0.93 (3H, d, J = 6.6 Hz, H-17), 0.88 (3H, m, H-19); HRMS
(ESI): calcd for C20H37O2 ([MꢁOH]+) 309.2788, found 309.2777;
calcd for C20H38O3Na ([M+Na]+) 349.2713, found 349.2689.
4.3.6. 15-Epi-a1 (10)
Total synthesis of this
a
1 isomer is described in Supplementary
= –12.4 (c 0.6, MeOH); IR (film): max = 3374 (br),
1H NMR
data. 10: ½a 2D3
ꢂ
m
2935, 1705, 1121, 1049, 939, 917, 737, 618 cmꢁ1
;
(400 MHz, CD3OD): d = 3.52 (2H, br. t, J = 6.6 Hz, H-1), 3.41 (1H,
dd, J = 6.6, 10.7 Hz, H-16b), 3.33 (1H, m, H-16a), 2.76 (1H, sex,
J = 6.8 Hz, H-3), 2.53 (2H, t, J = 7.1 Hz, H-5), 1.89 (1H, sex,
J = 6.8 Hz, H-2b), 1.10–1.66 (15H, m), 1.12 (3H, s, H-18), 1.10 (2H,
m, H-8a, 14a), 1.07 (3H, d, J = 6.8 Hz, H-20), 0.91 (3H, d,
J = 6.8 Hz, H-17), 0.89 (3H, d, J = 6.4 Hz, H-19); 13C NMR
(100 MHz, CD3OD): d = 16.9 (C-20), 17.1 (C-17), 19.9 (C-19), 22.3
(C-9 or 13), 22.4 (C-13 or 9), 27.0 (C-18), 31.7 (C-6), 33.6 (C-7),
35.0 (C-14), 36.7 (C-2), 36.9 (C-15), 38.6 (C-8), 40.0 (C-5), 42.9
(C-10 or 12), 43.0 (C-12 or 10), 43.9 (C-3), 60.6 (C-1), 68.4 (C-16),
73.4 (C-11), 217.5 (C-4). These NMR spectra are superimposable
4.3.9. 11-O-Acetyl-
To a stirred solution of bis-TBS-
pyridine (0.5 mL) were added DMAP (15 mg, 0.12 mmol) and acetic
anhydride (10 L, 0.11 mmol), and the mixture was stirred for 84 h
at room temperature. The mixture was poured into water. The
aqueous mixture was extracted with EtOAc, and the combined or-
ganic layers were washed with saturated aqueous CuSO4 solution,
water and brine. The organic layer was dried with Na2SO4, and con-
centrated. The residue was purified by silica gel column chroma-
tography with EtOAc-hexane (1:100) to give crude acetate
(4 mg). This was dissolved in THF (0.5 mL), and TBAF (1.0 M in
a2 (15)
a2 (26) (8 mg, 0.015 mmol) in
l
on those of
a
1 (1). Anal. Calcd for C20H40O4: C, 69.72; H, 11.70.
THF 14 lL, 14 lmol) was added to the resulting solution at 0 °C.
Found: C, 69.92; H, 11.86.
After stirred for 7 h at room temperature, the reaction was
quenched with water. The aqueous mixture was extracted with
EtOAc, and the combined organic layers were washed with brine,
dried with Na2SO4, and concentrated. The residue was purified
by silica gel column chromatography with EtOAc-hexane (3:2)
4.3.7. 3-Demethyl a1 (11)
Total synthesis of this derivative is described in Supplementary
data. 11: Colorless oil; ½a D25
ꢂ
= –2.0 (c 0.10, MeOH), IR (film):